Salt Lake City, UT, April 30, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced that Chris Gibson ...
Recursion (NASDAQ: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced that Chris Gibson ...
Bill McGlashan served time for trying to buy his son’s way into college during the Varsity Blues scandal. He hopes his new ...
Eighteen national symposia, held across 14 cities where leaders representing academic medicine, public health, ...
Students, faculty, and staff from the School of Computational Science and Engineering (CSE) were among those recognized at ...
The Templeton Prize, awarded by the John Templeton Foundation, is one of the world’s largest annual individual awards. It is ...
Purifying novel therapeutics remains a major challenge as increasingly complex molecules move towards the clinic. With Lonza, you can ensure optimal product quality and bring your molecules to the ...
Colossal Biosciences, the world's first de-extinction company, announces the bluebuck as the sixth species in its de-extinction portfolio. The bluebuck (Hippotragus leucophaeus), which disappeared in ...
Daily Mail on MSN
Company attempting to bring back the woolly mammoth reveals plan to 'de-extinct' the bluebuck
The company behind the scheme to 'de-extinct' the woolly mammoth has set its sights on the bluebuck - an extinct species of ...
Myelin is a sheath around the nerves made by certain brain cells called oligodendrocytes. These cells arise from progenitor ...
AI-guided redesign of protein alphabet in bacteria could unlock new ways to build synthetic organisms.
Colossal Biosciences, the world's first de-extinction company, today announced the bluebuck ( Hippotragus leucophaeus) as the sixth species in its de-extinction portfolio. Hunted to extinction for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results